Stay updated on Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content or version of the webpage.
    Difference
    0.3%
    Check dated 2024-06-13T22:12:26.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in medical or healthcare-related publications or documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:25:19.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value on the webpage has been updated from 6 to 7, indicating a recent change in the number of relevant medical or healthcare-related publications or documentation. This update may reflect new information or additional studies being included in the database.
    Difference
    0.3%
    Check dated 2024-05-22T21:25:23.000Z thumbnail image
  8. Check
    26 days ago
    Change Detected
    Summary
    The value 2023 12 has been updated to 2024 05 on the webpage, indicating a recent change in the study record related to Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN). This change may be significant for individuals monitoring medical and healthcare-related publications and documentation.
    Difference
    0.7%
    Check dated 2024-05-21T15:34:19.000Z thumbnail image
  9. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:31:40.000Z thumbnail image

Stay in the know with updates to Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.